TY - JOUR
T1 - Structure-activity relationship study on 13-deoxytedanolide, a highly antitumor macrolide from the marine sponge Mycale adhaerens
AU - Nishimura, Shinichi
AU - Matsunaga, Shigeki
AU - Yoshida, Satoru
AU - Nakao, Yoichi
AU - Hirota, Hiroshi
AU - Fusetani, Nobuhiro
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2005/1/17
Y1 - 2005/1/17
N2 - Structure-activity relationship of 13-deoxytedanolide showed that the southern and northern hemispheres play independent roles to exhibit potent biological activity. To obtain information of structure-activity relationships (SARs) of 13-deoxytedanolide, its chemical transformation has been carried out, targeting on such functional groups as an epoxide, hydroxyls, ketones, and olefins. A total of 10 derivatives have been prepared and their cytotoxicity against P388 murine leukemia cells and inhibitory activity of polypeptide elongation in yeast cell lysate provided some important SARs; the southern hemisphere comprises the pharmacophore, while the epoxide-bearing side chain is essential for the activity.
AB - Structure-activity relationship of 13-deoxytedanolide showed that the southern and northern hemispheres play independent roles to exhibit potent biological activity. To obtain information of structure-activity relationships (SARs) of 13-deoxytedanolide, its chemical transformation has been carried out, targeting on such functional groups as an epoxide, hydroxyls, ketones, and olefins. A total of 10 derivatives have been prepared and their cytotoxicity against P388 murine leukemia cells and inhibitory activity of polypeptide elongation in yeast cell lysate provided some important SARs; the southern hemisphere comprises the pharmacophore, while the epoxide-bearing side chain is essential for the activity.
KW - 13-Deoxytedanolide
KW - Antitumor
KW - Cytotoxicity
KW - Marine sponge-derived macrolide
KW - Protein synthesis inhibition
KW - SAR
UR - http://www.scopus.com/inward/record.url?scp=10444285046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=10444285046&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2004.10.014
DO - 10.1016/j.bmc.2004.10.014
M3 - Article
C2 - 15598567
AN - SCOPUS:10444285046
SN - 0968-0896
VL - 13
SP - 455
EP - 462
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 2
ER -